EP Patent

EP0233849A1 — Composition of pregnanolole comprising a stable oil-in-water emulsion

Assigned to Pfizer Health AB · Expires 1987-08-26 · 39y expired

What this patent protects

A composition for intravenous administration of 3-alfa-hydroxy-­5-beta-pregnan-20-one (pregnanolone), comprising a stable oil-in-water emulsion, capable of being sterilized by auto­claving, of from 0.1 to 1.0 g of pregnanolone.

USPTO Abstract

A composition for intravenous administration of 3-alfa-hydroxy-­5-beta-pregnan-20-one (pregnanolone), comprising a stable oil-in-water emulsion, capable of being sterilized by auto­claving, of from 0.1 to 1.0 g of pregnanolone.

Drugs covered by this patent

Patent Metadata

Patent number
EP0233849A1
Jurisdiction
EP
Classification
—
Expires
1987-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Health AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.